狂犬病疫苗市场 - 按产品类型 [婴儿仓鼠肾 (BHK)、Vero 细胞狂犬病疫苗]、类型（人用、兽用）、应用（暴露前预防、暴露后预防）、配销通路、全球预测（2024 年- 2032 年）

Rabies Vaccine Market - By Product Type [Baby Hamster Kidney (BHK), Vero Cell Rabies Vaccine], Type (Human, Veterinary), Application (Pre-Exposure Prophylaxis, Post Exposure Prophylaxis), Distribution Channel, Global Forecast (2024 - 2032)

出版日期: 2024年06月13日 | 出版商:

Global Market Insights Inc. | 英文 149 Pages | 商品交期: 2-3个工作天内

价格

简介目录

在疫苗技术进步和医疗基础设施扩张的推动下，狂犬病疫苗市场规模预计 2024 年至 2032 年复合年增长率将达到 4.5%。疫苗研究的不断发展正在催生更有效、更容易接种的疫苗，以增强对狂犬病的保护。

对医疗基础设施的日益关注正在改善疫苗的分发和可及性，特别是在狂犬病较为流行的地区。此外，改进疫苗配方和增加全球供应的不断努力将推动市场成长。例如，2022年8月，卡迪拉製药公司推出了世界上第一个针对狂犬病的新型3剂量疫苗，透过简化的给药方案加强狂犬病的预防，标誌着在对抗这种致命疾病的斗争中取得了重大进展。

整个市场分为产品类型、类型、应用、配销通路和区域。

就类型而言，在改善动物健康和加强疾病控制的推动下，狂犬病疫苗市场的兽医部分可能会在 2032 年显着增长。持续的进步正在为宠物和牲畜提供更有效、更持久的疫苗铺平道路，以提供更好的狂犬病保护。改良的兽用疫苗可以防止狂犬病从动物传播给人类并控制疫情。

从配销通路来看，由于消费者对让宠物主人和兽医更容易获得狂犬病疫苗的需求不断增长，在线药房领域的狂犬病疫苗行业价值预计将在 2024 年至 2032 年期间上升。这一转变使得能够更轻鬆地采购疫苗以供立即使用和管理狂犬病预防方案。线上平台也致力于简化订购流程，并确保疫苗在运输过程中得到适当的储存和处理。

从区域来看，在狂犬病发病率上升以及意识和预防计划不断增强的推动下，亚太地区狂犬病疫苗市场规模预计将在 2024 年至 2032 年间呈现强劲增长。卫生组织和政府正在促进狂犬病疫苗接种并提高公众对预防策略的了解。此外，加强预防措施和疫苗接种覆盖率正在控制狂犬病疫情并降低发病率，从而促进了区域产业的成长。

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 荷兰
- 欧洲其他地区
亚太地区
- 中国
- 日本
- 印度
- 澳洲
- 韩国
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 拉丁美洲其他地区
中东和非洲
- 南非
- 沙乌地阿拉伯
- 阿联酋
- 中东和非洲其他地区

第 10 章：公司简介

Bavarian Nordic A/S
Bharat Biotech International Limited
Bio-Manguinhos/Fiocruz
Cadila Pharmaceuticals
China National Biotec Group Co.
Elanco Animal Health Incorporated
GSK plc.
Indian Immunologicals Ltd.
Liaoning Chengda Biological
Merck & Co., Inc.
Novartis AG
Sanofi SA
Serum Institute of India Pvt. Ltd
Virbac
Zoetis Inc.

简介目录

Product Code: 9865

Rabies Vaccine Market size is projected to record 4.5% CAGR from 2024 to 2032, driven by advancements in vaccine technologies and the expansion of healthcare infrastructure. Ongoing developments in vaccine research are leading to more effective and easier-to-administer vaccines for enhancing protection against rabies.

The surging focus on healthcare infrastructure is improving vaccine distribution and accessibility, especially in regions where rabies is more prevalent. Moreover, the growing efforts on refining vaccine formulations and increasing global availability will drive the market growth. For instance, in August 2022, Cadila Pharma launched the world's first novel 3-dose vaccine against rabies to enhance rabies prevention with a streamlined dosing schedule for marking a significant advancement in the fight against this deadly disease.

The overall market is segregated into product type, type, application, distribution channel, and region.

In terms of type, the veterinary segment in the rabies vaccine market may experience significant growth by 2032, propelled by increasing adoption to improve animal health and enhance disease control. Ongoing advancements are making way for more effective and longer-lasting vaccines for pets and livestock to provide better protection against rabies. Improved veterinary vaccines are preventing rabies transmission from animals to humans as well as in controlling outbreaks.

By distribution channel, the rabies vaccine industry value from the online pharmacy segment is projected to rise from 2024 to 2032, driven by increasing consumer demand for making rabies vaccine more accessible to pet owners and veterinarians. This shift is enabling easier procurement of vaccines for immediate use and for managing rabies prevention protocols. Online platforms are also working on streamlining the ordering process and ensuring proper storage and handling of the vaccines during shipping.

Regionally, the Asia Pacific rabies vaccine market size is projected to exhibit robust growth between 2024 and 2032, fueled by the rising incidences of rabies and the increasing awareness and prevention programs. Health organizations and governments are promoting rabies vaccination and enhancing public knowledge about prevention strategies. Moreover, enhanced preventive measures and vaccination coverage are controlling rabies outbreaks and reducing incidence rates, adding to the regional industry growth.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing incidence of rabies
  - 3.2.1.2 Technological advancements in vaccine production
  - 3.2.1.3 Growing pet population
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High cost of vaccines
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technology landscape
3.6 Pipeline analysis
3.7 Future market trends
3.8 Porter's analysis
3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Baby hamster kidney (BHK)
5.3 Purified chick embryo cell rabies vaccine
5.4 Vero cell rabies vaccine
5.5 Other product types

Chapter 6 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Human
6.3 Veterinary

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Pre exposure prophylaxis
7.3 Post exposure prophylaxis

Chapter 8 Market Estimates and Forecast, By Distribution Channel, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 Hospital pharmacy
8.3 Retail pharmacy
8.4 Online pharmacy

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

9.1 Key trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Netherlands
- 9.3.7 Rest of Europe
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Rest of Latin America
9.6 Middle East and Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 UAE
- 9.6.4 Rest of Middle East and Africa